Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Feasibility Trial Using an Inpatient Insulin Dosing Calculator: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Trial Using an Inpatient Insulin Dosing Calculator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06206525).
- FEATUREIndependent statistical analysis of A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy: primary endpoint results, effect estimate with confidence…
- Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn’s Colitis: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fecal Microbiota Transplantation (FMT) for MDRO UTI: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplantation (FMT) for MDRO UTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367910).
- Fentanyl for Breakthrough Pain in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl for Breakthrough Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01812759).
- Fetal Tracheal Balloon Study in Diaphragmatic Hernia: Complete Statistical AnalysisIndependent statistical analysis of Fetal Tracheal Balloon Study in Diaphragmatic Hernia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966823).
- Fetoscopic NEOX Cord 1K® Spina Bifida Repair: Complete Statistical AnalysisIndependent statistical analysis of Fetoscopic NEOX Cord 1K® Spina Bifida Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243889).
- Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: Complete Statistical AnalysisIndependent statistical analysis of Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03974178).
- FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03212170).
- Fibrin Glue in Inguinal Lymphadenectomy: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Glue in Inguinal Lymphadenectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04666051).
- Fibrin Melanoma Axillary Node Study in Patients With Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Melanoma Axillary Node Study in Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504582).
- Fibrin Sealant Vascular Surgery Study: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Sealant Vascular Surgery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00576420).
- FIDELIO-DKDIndependent statistical analysis of Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FIGARO UC 303Independent statistical analysis of An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FIGHT-210Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration: primary endpoint results, effect…
- Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02210832).
- FINCH 1Independent statistical analysis of Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate: primary endpoint results, effect estimate with confidence…
- FireballIndependent statistical analysis of A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- FIREFLEYEIndependent statistical analysis of Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FIRSTIndependent statistical analysis of Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma: primary endpoint results, effect estimate with…
- First – In – Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: Complete Statistical AnalysisIndependent statistical analysis of First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: primary endpoint results, effect…
- First HeroesIndependent statistical analysis of First Heroes: Engaging Fathers in the First 1000 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04477577).
- First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone: Complete Statistical AnalysisIndependent statistical analysis of First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone: primary endpoint results, effect estimate with confidence interval,…
- First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent: Complete Statistical AnalysisIndependent statistical analysis of First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Complete Statistical AnalysisIndependent statistical analysis of First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High…
- First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: primary endpoint results, effect estimate with…
- First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FISATABIIndependent statistical analysis of Feasibility of Improving Sleep Apnea Treatment Adherence After Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04221009).
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01285362).
- Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): Complete Statistical AnalysisIndependent statistical analysis of Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): primary endpoint results, effect estimate with confidence…
- FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): Complete Statistical AnalysisIndependent statistical analysis of FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): primary endpoint results, effect estimate with confidence…
- Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: Complete Statistical AnalysisIndependent statistical analysis of Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05646355).
- FLAXPADIndependent statistical analysis of Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Flex HDIndependent statistical analysis of Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or…
- FLEX MIndependent statistical analysis of A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FLEX VIndependent statistical analysis of A Study in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01202773).
- Flex-UpIndependent statistical analysis of A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence…
- FLOWIndependent statistical analysis of A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence…
- FLUBUTBIIndependent statistical analysis of Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01366612).
- Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: Complete Statistical AnalysisIndependent statistical analysis of Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Fluid Balance in the ICU – Interventions to Minimize Fluids in Patients With Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…